1. Differential localization of PD-L1 and Akt-1 involvement in radioresistant and radiosensitive cell lines of head and neck squamous cell carcinoma. (22nd October 2019) Authors: Schulz, D; Streller, M; Piendl, G; Brockhoff, G; Reichert, T E; Menevse, A N; Beckhove, P; Hautmann, M G; Bauer, R J; Ettl, T Journal: Carcinogenesis Issue: Volume 41:Number 7(2020) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P01.031 VXM01 phase I study in patients with progressive glioblastoma - final results. (19th September 2018) Authors: Wick, W; Wick, A; Sahm, F; Riehl, D; von Deimling, A; Bendszus, M; Mickingereder, P; Beckhove, P; Schmitz Winnenthal, F; Jungk, C; Wieckoswski, S; Keller, A; Podola, L; Herold-Mende, C; Lubenau, H; Unterberg, A; Platten, M J Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. (15th April 2015) Authors: Schneider, T; Sevko, A; Heussel, C P; Umansky, L; Beckhove, P; Dienemann, H; Safi, S; Utikal, J; Hoffmann, H; Umansky, V Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗